Baudax Bio
Stock Forecast, Prediction & Price Target
Baudax Bio Financial Estimates
Baudax Bio Revenue Estimates
Baudax Bio EBITDA Estimates
Baudax Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $493K N/A | $1.08M 119.06% | $1.26M 17.5% | Avg: $5.07M Low: $5.07M High: $5.07M avg. 300% | |||
Net Income
% change YoY
| $-76.1M N/A | $-19.76M 74.02% | $-58.79M -197.41% | Avg: $-23.53M Low: $-261.97K High: $-261.97K avg. 59.96% | |||
EBITDA
% change YoY
| $-74.78M N/A | $-48.26M 35.46% | $-12.67M 73.73% | Avg: $-1.01M Low: $-1.01M High: $-1.01M avg. 91.99% | |||
EPS
% change YoY
| -$5,715.36 N/A | -$361.16 93.68% | -$177.3 50.90% | Avg: -$0.79 Low: -$0.79 High: -$0.79 avg. 99.55% | |||
Operating Expenses
% change YoY
| $54.56M N/A | $51.01M -6.51% | $30.00M -41.18% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Baudax Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 59.96% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -261.97K, average is -23.53M and high is -261.97K.
What is Baudax Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 300% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $5.07M, average is $5.07M and high is $5.07M.
What is Baudax Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 99.55% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.79, average is -$0.79 and high is $-0.79.